Biotechnology Law Report最新文献

筛选
英文 中文
Arbutus Biopharma Corp. v. ModernaTX, Inc. Arbutus Biopharma Corp.诉ModernaTX,股份有限公司。
IF 0.2 4区 生物学
Biotechnology Law Report Pub Date : 2023-05-30 DOI: 10.1089/blr.2023.29311.cip
Christopher M. Holman
{"title":"Arbutus Biopharma Corp. v. ModernaTX, Inc.","authors":"Christopher M. Holman","doi":"10.1089/blr.2023.29311.cip","DOIUrl":"https://doi.org/10.1089/blr.2023.29311.cip","url":null,"abstract":"","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41626033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Legislative Paradigm of China's Biosafety Law and Its Positive Significance for the SARS-CoV-2 Prevention and Control 中国生物安全法立法范式及其对新冠肺炎防控的积极意义
IF 0.2 4区 生物学
Biotechnology Law Report Pub Date : 2023-05-24 DOI: 10.1089/blr.2023.29307.ww
Zhou Chen, Wu Wanqiang
{"title":"The Legislative Paradigm of China's Biosafety Law and Its Positive Significance for the SARS-CoV-2 Prevention and Control","authors":"Zhou Chen, Wu Wanqiang","doi":"10.1089/blr.2023.29307.ww","DOIUrl":"https://doi.org/10.1089/blr.2023.29307.ww","url":null,"abstract":"","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43838392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
China Releases Document on Ethics Review of Life Sciences: Comments and Compliance Guidelines 中国发布生命科学伦理审查文件:意见与合规指南
IF 0.2 4区 生物学
Biotechnology Law Report Pub Date : 2023-05-24 DOI: 10.1089/blr.2023.29308.hp
Wang Gang, Huang Peng
{"title":"China Releases Document on Ethics Review of Life Sciences: Comments and Compliance Guidelines","authors":"Wang Gang, Huang Peng","doi":"10.1089/blr.2023.29308.hp","DOIUrl":"https://doi.org/10.1089/blr.2023.29308.hp","url":null,"abstract":"","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47681149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Biotechnology and Intellectual Property Law: Theoretical and Practical Reflections on Albanian National Law and Jurisprudence in Comparison with EU Acquis and ECJ Case Law 生物技术和知识产权法:阿尔巴尼亚国家法律和法学的理论与实践思考——与欧盟和欧洲法院判例法的比较
IF 0.2 4区 生物学
Biotechnology Law Report Pub Date : 2023-05-22 DOI: 10.1089/blr.2023.29309.xs
Laura Çami (Vorpsi), Xhon Skënderi
{"title":"Biotechnology and Intellectual Property Law: Theoretical and Practical Reflections on Albanian National Law and Jurisprudence in Comparison with EU Acquis and ECJ Case Law","authors":"Laura Çami (Vorpsi), Xhon Skënderi","doi":"10.1089/blr.2023.29309.xs","DOIUrl":"https://doi.org/10.1089/blr.2023.29309.xs","url":null,"abstract":"","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43951616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative mometasone irrigations improve quality of life in skull base tumor patients. 术后莫米松冲洗改善颅底肿瘤患者的生活质量。
4区 生物学
Biotechnology Law Report Pub Date : 2023-05-16 eCollection Date: 2023-12-01 DOI: 10.1002/wjo2.99
Mandy K Salmon, Rijul S Kshirsagar, Jacob G Eide, Auddie M Sweis, Kathleen Davin, Aman Prasad, Heather Ungerer, Elizabeth Stevens, Kevin Ig-Izevbekhai, Siddhant Tripathi, Tran B Locke, Theodore Lin, Brian M Sweis, Michael A Kohanski, Nithin D Adappa, James N Palmer
{"title":"Postoperative mometasone irrigations improve quality of life in skull base tumor patients.","authors":"Mandy K Salmon, Rijul S Kshirsagar, Jacob G Eide, Auddie M Sweis, Kathleen Davin, Aman Prasad, Heather Ungerer, Elizabeth Stevens, Kevin Ig-Izevbekhai, Siddhant Tripathi, Tran B Locke, Theodore Lin, Brian M Sweis, Michael A Kohanski, Nithin D Adappa, James N Palmer","doi":"10.1002/wjo2.99","DOIUrl":"10.1002/wjo2.99","url":null,"abstract":"<p><strong>Objectives: </strong>The use of topical corticosteroids to manage postoperative sinonasal symptoms after endoscopic skull base surgery (ESBS) has not been well studied. We quantified long-term impact of postoperative steroid irrigations (SIs) on quality of life of patients after ESBS.</p><p><strong>Methods: </strong>Retrospective review of patients at the University of Pennsylvania undergoing ESBS from 2010 to 2019. Data on patient demographics and postoperative treatment with nasal saline irrigation twice daily with and without dissolved steroids (mometasone or budesonide) was collected. Preoperative, and 1-, 3-, 6-, 12-, 18-, and 24-month postoperative Sino-Nasal Outcome Test (SNOT-22) scores were assessed.</p><p><strong>Results: </strong>A total of 727 patients were assessed (53.4% males), with 479 patients in the no SI group and 248 patients in the SI group. Preoperative SNOT-22 scores did not differ significantly (<i>P</i> = 0.19). 1-, 3-, 6-, 12-, 18-, and 24-month post-op SNOT-22 scores did not significantly differ between groups. However, mometasone irrigations resulted in significantly lower postoperative 2-year SNOT-22 scores compared to budesonide (<i>P</i> < 0.01) and saline (<i>P</i> = 0.03).</p><p><strong>Conclusions: </strong>Though corticosteroid irrigations are routine in managing inflammatory sinus disease, their role in postoperative management after ESBS for tumors is unclear. Our findings suggest that mometasone irrigation may be effective at improving postoperative quality of life in patients after ESBS.</p>","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":"16 1","pages":"314-319"},"PeriodicalIF":0.0,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82894140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 2023 Review of Legislation Aimed at Increasing Generic and Biosimilar Competition 2023年旨在增加仿制药和生物仿制药竞争的立法审查
IF 0.2 4区 生物学
Biotechnology Law Report Pub Date : 2023-04-01 DOI: 10.1089/blr.2023.29303.cmh
Christopher M. Holman
{"title":"A 2023 Review of Legislation Aimed at Increasing Generic and Biosimilar Competition","authors":"Christopher M. Holman","doi":"10.1089/blr.2023.29303.cmh","DOIUrl":"https://doi.org/10.1089/blr.2023.29303.cmh","url":null,"abstract":"","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48141858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected Developments in Biotechnology Law and the Biotechnology Industry 生物技术法和生物技术产业的若干发展
4区 生物学
Biotechnology Law Report Pub Date : 2023-04-01 DOI: 10.1089/blr.2023.29302.sjz
STEVEN J. ZWEIG
{"title":"Selected Developments in Biotechnology Law and the Biotechnology Industry","authors":"STEVEN J. ZWEIG","doi":"10.1089/blr.2023.29302.sjz","DOIUrl":"https://doi.org/10.1089/blr.2023.29302.sjz","url":null,"abstract":"Biotechnology Law ReportVol. 42, No. 2 News BriefsSelected Developments in Biotechnology Law and the Biotechnology IndustryBy Steven J. ZweigBy Steven J. ZweigSteven J. Zweig is the Managing Editor of Biotechnology Law Report.Search for more papers by this authorPublished Online:6 Apr 2023https://doi.org/10.1089/blr.2023.29302.sjzAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 42Issue 2Apr 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:By Steven J. Zweig.Selected Developments in Biotechnology Law and the Biotechnology Industry.Biotechnology Law Report.Apr 2023.65-67.http://doi.org/10.1089/blr.2023.29302.sjzPublished in Volume: 42 Issue 2: April 6, 2023Online Ahead of Print:March 24, 2023PDF download","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136148924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Minerva Surgical, Inc. v. Hologic, Inc. United States Court of Appeals of the Federal Circuit, 2023 59 F.4th 1371 Minerva Surgical公司诉Hologic公司案美国联邦巡回上诉法院,2023年59 f .4 1371
4区 生物学
Biotechnology Law Report Pub Date : 2023-04-01 DOI: 10.1089/blr.2023.29306.cip
Christopher M. Holman
{"title":"Minerva Surgical, Inc. v. Hologic, Inc. <i>United States Court of Appeals of the Federal Circuit, 2023 59 F.4th 1371</i>","authors":"Christopher M. Holman","doi":"10.1089/blr.2023.29306.cip","DOIUrl":"https://doi.org/10.1089/blr.2023.29306.cip","url":null,"abstract":"Biotechnology Law ReportVol. 42, No. 2 Minerva Surgical, Inc. v. Hologic, Inc. United States Court of Appeals of the Federal Circuit, 2023 59 F.4th 1371Edited for Biotechnology Law Report by Christopher M. HolmanEdited for Biotechnology Law Report by Christopher M. HolmanChristopher M. Holman is a Professor of Law at the University of Missouri-Kansas City School of Law; a Senior Scholar at the Center for the Protection of Intellectual Property at the Antonin Scalia Law School, George Mason University; and the Executive Editor of Biotechnology Law Report.*The synopsis is original content and the decision itself has been condensed for ease of readability.Search for more papers by this authorPublished Online:6 Apr 2023https://doi.org/10.1089/blr.2023.29306.cipAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 42Issue 2Apr 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Edited for Biotechnology Law Report by Christopher M. Holman.Minerva Surgical, Inc. v. Hologic, Inc. United States Court of Appeals of the Federal Circuit, 2023 59 F.4th 1371.Biotechnology Law Report.Apr 2023.108-114.http://doi.org/10.1089/blr.2023.29306.cipPublished in Volume: 42 Issue 2: April 6, 2023Online Ahead of Print:March 30, 2023PDF download","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135275105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ChromaDex, Inc. v. Elysium Health, Inc. ChromaDex公司诉Elysium Health公司案
IF 0.2 4区 生物学
Biotechnology Law Report Pub Date : 2023-03-30 DOI: 10.1089/blr.2023.29304.cip
Christopher M. Holman
{"title":"ChromaDex, Inc. v. Elysium Health, Inc.","authors":"Christopher M. Holman","doi":"10.1089/blr.2023.29304.cip","DOIUrl":"https://doi.org/10.1089/blr.2023.29304.cip","url":null,"abstract":"","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43023056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jazz Pharms., Inc. v. Avadel CNS Pharms., LLC Jazz Pharms,Inc.v.Avadel CNS Pharms,LLC公司
IF 0.2 4区 生物学
Biotechnology Law Report Pub Date : 2023-03-30 DOI: 10.1089/blr.2023.29305.cip
Christopher M. Holman
{"title":"Jazz Pharms., Inc. v. Avadel CNS Pharms., LLC","authors":"Christopher M. Holman","doi":"10.1089/blr.2023.29305.cip","DOIUrl":"https://doi.org/10.1089/blr.2023.29305.cip","url":null,"abstract":"","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41400620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信